|
Journal of Lipid Research, Vol. 41, 58-65, January 2000
Copyright © 2000 by Lipid Research, Inc.
Transthyretin in high density lipoproteins: association with apolipoprotein A-I
Mónica Mendes Sousaa,b,
Lars Berglundc, and
Maria João Saraivaa,b
a Amyloid Unit, Columbia University, New York, NY
b Instituto de Biologia Molecular e Celular and Instituto de Ciências Biomédicas Abel Salazar, Columbia University, New York, NY
c Universidade do Porto, Portugal, and Department of Medicine, Columbia University, New York, NY
Correspondence to:
Maria João Saraiva
Previous studies have revealed the presence of transthyretin (TTR) on lipoproteins. To further address this issue, we fractionated plasma lipoproteins from 9 normal individuals, 10 familial amyloidotic polyneuropathy (FAP) patients, and 19 hyperlipidemic subjects using gel filtration. In the majority of the subjects, as well as in 9 of the 10 FAP patients and 14 of the 19 patients with hyperlipidemia, TTR was detected by ELISA in the high density lipoprotein (HDL) fraction. The presence of TTR in HDL was confirmed by direct sequencing and by immunoblotting; using non-reducing conditions, TTR was found by immunoblotting in a high molecular weight complex, which reacted also for apolipoprotein A-I (apoA-I). The amount of TTR present in HDL (HDL-TTR), as quantified by ELISA corresponded to 1;2% of total plasma TTR. However, no detectable TTR levels were found in HDL fraction from 6 of the hyperlipidemic subjects. No correlation was found between the lack of TTR in HDL and plasma levels of total, LDL-, or HDL-associated cholesterol as well as levels of apoA-I and total plasma TTR. Ligand binding experiments showed that radiolabeled TTR binds to the HDL fraction of individuals with HDL-TTR but not to the corresponding fractions of individuals devoid of HDL-TTR, suggesting that HDL composition may interfere with TTR binding. The component(s) to which TTR binds in the HDL fraction were investigated.
Polyclonal antibody against apoA-I was able to block the interaction of TTR with HDL, suggesting that the interaction of TTR with the HDL particle occurs via apoA-I. This hypothesis was further demonstrated by showing the formation of a complex of TTR with HDL and apoA-I by crosslinking experiments. Furthermore, anti-apoA-I immunoblot under native conditions suggested the existence of differences in HDL particle properties and/or stability between individuals with and without HDL-TTR.Sousa, M. M., L. Berglund, and M. J. Saraiva. Transthyretin in high density lipoproteins: association with apolipoprotein A-I. J. Lipid Res. 2000. 41: 58;65.
Supplementary key words:
amyloidosis, high density lipoproteins, transthyretin, apolipoprotein A-I

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. A. Liz, C. M. Gomes, M. J. Saraiva, and M. M. Sousa
ApoA-I cleaved by transthyretin has reduced ability to promote cholesterol efflux and increased amyloidogenicity
J. Lipid Res.,
November 1, 2007;
48(11):
2385 - 2395.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. M. Wilson, C. L. L. Pham, A. J. Jenkins, J. D. Wade, A. F. Hill, M. A. Perugini, and G. J. Howlett
High density lipoproteins bind A{beta} and apolipoprotein C-II amyloid fibrils
J. Lipid Res.,
April 1, 2006;
47(4):
755 - 760.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Refai, N. Dekki, S.-N. Yang, G. Imreh, O. Cabrera, L. Yu, G. Yang, S. Norgren, S. M. Rossner, L. Inverardi, et al.
Transthyretin constitutes a functional component in pancreatic {beta}-cell stimulus-secretion coupling
PNAS,
November 22, 2005;
102(47):
17020 - 17025.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. K. O'Bryan, L. M. Foulds, J. F. Cannon, W. R. Winnall, J. A. Muir, K. Sebire, A. I. Smith, H.-H. Keah, M. T. W. Hearn, D. M. de Kretser, et al.
Identification of a Novel Apolipoprotein, ApoN, in Ovarian Follicular Fluid
Endocrinology,
November 1, 2004;
145(11):
5231 - 5242.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C Torricelli, E Capurro, A Santucci, A Paffetti, C D'Ambrosio, A Scaloni, E Maioli, and A Pacini
Multiple plasma proteins control atrial natriuretic peptide (ANP) aggregation
J. Mol. Endocrinol.,
October 1, 2004;
33(2):
335 - 341.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. A. Liz, C. J. Faro, M. J. Saraiva, and M. M. Sousa
Transthyretin, a New Cryptic Protease
J. Biol. Chem.,
May 14, 2004;
279(20):
21431 - 21438.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. M. Sousa, R. Fernandes, J. A. Palha, A. Taboada, P. Vieira, and M. J. Saraiva
Evidence for Early Cytotoxic Aggregates in Transgenic Mice for Human Transthyretin Leu55Pro
Am. J. Pathol.,
November 1, 2002;
161(5):
1935 - 1948.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. M. de Sousa, C. Vital, D. Ostler, R. Fernandes, J. Pouget-Abadie, D. Carles, and M. J. Saraiva
Apolipoprotein AI and Transthyretin as Components of Amyloid Fibrils in a Kindred with apoAI Leu178His Amyloidosis
Am. J. Pathol.,
June 1, 2000;
156(6):
1911 - 1917.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. M. Sousa and M. J. Saraiva
Internalization of Transthyretin. EVIDENCE OF A NOVEL YET UNIDENTIFIED RECEPTOR-ASSOCIATED PROTEIN (RAP)-SENSITIVE RECEPTOR
J. Biol. Chem.,
April 20, 2001;
276(17):
14420 - 14425.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2000 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|